- Lobbying
- Lobbying by RWE Alliance Inc.
Lobbying Relationship
Bills mentioned
H.R.4511: FACTS Act
Sponsor: Michael C. Burgess (R-Texas)
S.1508: A bill to provide for the use of emergency use authorization data and...
Sponsor: Roger Marshall (R-Kan.)
H.R.6000: Cures 2.0 Act
Sponsor: Diana DeGette (D-Colo.)
S.3799: PREVENT Pandemics Act
Sponsor: Patty Murray (D-Wash.)
S.4348: FDASLA Act of 2022
Sponsor: Patty Murray (D-Wash.)
H.R.7667: Food and Drug Amendments of 2022
Sponsor: Anna G. Eshoo (D-Calif.)
H.R.6833: Continuing Appropriations and Ukraine Supplemental Appropriations Act, 2023
Sponsor: Angie Craig (D-Minn.)
H.R.2617: Consolidated Appropriations Act, 2023
Sponsor: Gerald E. Connolly (D-Va.)
Lobbyists
Lobbyists named here were listed on a filing related to this lobbying engagement. They may not be working on it now. Occasionally, a single lobbyist whose name is spelled two different ways on filings may be represented twice here.
Lobbyist | Covered positions? |
---|---|
Morgan Schreurs | Senate Committee on Health, Education, Labor and Pensions, Oversight & Investigations Law Clerk (May-July 2016, August-December 2017) |
Wade Ackerman | Sr. FDA Counsel, U.S. Senate Committee on Health, Education, Labor & Pensions |
Disclosures Filed
Once a lobbying engagement begins, the lobbyist or firm is required to file updates four times a year. Those updates sometimes change which lobbyists are involved or add new issues being discussed. When lobbyists stop working for a client, the firm is also supposed to file a report disclosing the end of the relationship.
U.S. House of Representatives
Medical
Science
Medical
Science
Medical
Medical
U.S. House of Representatives
Medical
U.S. House of Representatives
Medical
U.S. House of Representatives
Medical
U.S. House of Representatives
Medical
Medical
U.S. House of Representatives
Medical
Source: Clerk of the U.S. House of Representatives and Secretary of the Senate